| Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
| Alexander Vinks, PHD |
Pharmacogenetics of Oxycodone, Personalized Care and Persistent Surgical Pain |
Indiana University Health (Ntl Inst of Child Health & Human Dev) |
R01HD089458 |
09/01/2018 - 08/31/2019 |
$67,446 |
| Alexander Vinks, PHD |
Electronic Health Record (EHR)-embedded Decision Support Platform for Individualized Precision Drug Treatmentin Neonates |
The Gerber Foundation |
Gerber |
10/01/2019 - 09/30/2020 |
$99,000 |
| Alexander Vinks, PHD |
First-In-Human Study of a Humanized Anti-Cocaine Monoclonal Antibody |
University of Cincinnati (National Institutes of Health) |
012264-003 |
07/01/2019 - 04/30/2020 |
$61,465 |
| Alexander Vinks, PHD |
Neonatal PBPK-PD Modeling of Morphine Incorporated with OCT1 Genotype-dependent Developmental Expression |
National Institutes of Health (NIH) |
1R21HD095418-01 |
07/01/2019 - 06/30/2020 |
$198,750 |
| Current Year Direct |
$426,661 |
